• English
  • Sign In
  • Contact Us
×
Catalog Products » Other Products » Catalog Peptides » All Catalog Peptides » CTTHWGFTLC, CYCLIC

CTTHWGFTLC, CYCLIC

Description This cyclic CTT Gelatinase Inhibitor peptide is an inhibitor for matrix metalloproteinases (MMP)-2 and MMP-9. It is also called type IV collagenase or gelatinase. Gelatinases are potential targets of therapeutic intervention in cancer, and inhibitors of these enzymes can prevent tumor progression. Cyclic CTT inhibits the migration of human endothelial cells and tumor cells. It prevents tumor growth and invasion. Inhibitors, complexed with their target proteinases, can be taken up into cells by endocytosis, and CTT added to liposomes enhances their uptake by tumor cells, thus providing possibility of liposomal delivery of chemotherapeutic agents. MMP-2 inhibition with cyclic CTT is also important in hypoxia studies.
Sequence
{Cys}{Thr}{Thr}{His}{Trp}{Gly}{Phe}{Thr}{Leu}{Cys}
Sequence Shortening CTTHWGFTLC
Molecular Formula C52H71N13O14S2
Disulfide Bridge Disulfide Bridge: 1-10
Molecular Weight 1166.34

Purity > 95%
Gmp Flag 0
Storage Store at -20°C. Keep tightly closed. Store in a cool dry place.
Note


Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H684-93. Epub 2006 Sep 15.Author:He JZ.

You can visit "Citations Database" for more citations.







For more documents, please visit "Technical Support".

Cat. No. RP20386
Size
Price
1 mg $86.00